HOLMES, Elizabeth

HOLMES, Elizabeth (b. February 3, 1984, Washington, D.C.), American entrepreneur and convicted fraudster who founded Theranos in 2003, claiming to have revolutionized blood testing technology, before being exposed in 2015 as operating an elaborate deception that misled investors, patients, and the medical community for over a decade.

Holmes founded Theranos while a sophomore at Stanford University, dropping out to pursue what she claimed would be a breakthrough in medical diagnostics. She asserted that her company had developed proprietary technology capable of performing hundreds of blood tests using only a few drops of blood from a finger prick, compared to traditional methods requiring full vials drawn from veins.

The company’s claimed technology, branded as “nanotainers” and “Edison” devices, purportedly could detect conditions ranging from diabetes to cancer using revolutionary miniaturized laboratory equipment. Holmes promoted these claims through media appearances, prestigious board appointments, and partnerships with major retailers including Walgreens, reaching a company valuation of $9 billion by 2014.

Investigative reporting by John Carreyrou at The Wall Street Journal beginning in 2015 revealed that Theranos’s technology was largely non-functional. The company was secretly using traditional machines from other manufacturers for most tests, often diluting tiny blood samples to dangerous degrees or producing unreliable results that could have led to misdiagnosis and patient harm.

Federal investigations revealed that Holmes had systematically deceived investors, regulators, doctors, and patients about the company’s capabilities. Internal documents showed that even Theranos executives knew the technology did not work as advertised, while Holmes continued publicly promoting false claims and using fabricated demonstrations to attract investment.

Following criminal charges filed in 2018, Holmes was convicted in January 2022 on four counts of fraud and conspiracy. She was sentenced to 11 years and 3 months in federal prison, with the court finding she had orchestrated a scheme to defraud investors of hundreds of millions of dollars while endangering patient safety through inaccurate medical tests.